Andromeda Surgical
Private Company
Funding information not available
Overview
Andromeda Surgical is a private, pre-revenue company pioneering an open, AI-driven surgical robotics platform. Founded in 2023 by entrepreneurs with deep expertise in medtech and autonomous systems, the company has already achieved a clinical milestone with the world's first robotic-assisted HoLEP procedure. By forging strategic partnerships with established medical device companies and leveraging a continuous software-update model, Andromeda aims to scale from urology into a multi-specialty platform that democratizes expert-level surgical care.
Technology Platform
Open, software-centric surgical platform featuring AI-guided spatial navigation ("Google Maps for the Human Body") and surgeon-in-the-loop autonomous task capabilities. It uses an iPad interface and integrates with existing surgical tools.
Opportunities
Risk Factors
Competitive Landscape
Andromeda enters a competitive market dominated by Intuitive Surgical, with major medtech players like Medtronic, Johnson & Johnson, and CMR Surgical also launching advanced robotic platforms. Its differentiation lies in its open, software-first approach, iPad-based interface, and focus on progressive autonomy rather than hardware complexity.